113 related articles for article (PubMed ID: 37149134)
1. Results of radiotherapy in oropharyngeal carcinomas.
León X; Farré N; Montezuma L; Holgado A; Vásquez R; Neumann E; Quer M
Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(3):137-147. PubMed ID: 37149134
[TBL] [Abstract][Full Text] [Related]
2. Oncological results of salvage treatment in patients with oropharynx carcinoma treated with radiotherapy.
León X; Neumann E; Holgado A; Vásquez R; Pujol A; Quer M
Acta Otorrinolaringol Esp (Engl Ed); 2024; 75(1):8-16. PubMed ID: 37393035
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.
Sedaghat AR; Zhang Z; Begum S; Palermo R; Best S; Ulmer KM; Levine M; Zinreich E; Messing BP; Gold D; Wu AA; Niparko KJ; Kowalski J; Hirata RM; Saunders JR; Westra WH; Pai SI
Laryngoscope; 2009 Aug; 119(8):1542-9. PubMed ID: 19522004
[TBL] [Abstract][Full Text] [Related]
5. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
Front Public Health; 2022; 10():900294. PubMed ID: 35958856
[TBL] [Abstract][Full Text] [Related]
6. Association between maximum standarised uptake value (SUV) and local control in patients with oropharyngeal carcinoma treated with radiotherapy.
Holgado A; León X; Quer M; Camacho V; Fernández A
Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(4):211-218. PubMed ID: 37149130
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus and survival of patients with oropharyngeal cancer.
Ang KK; Harris J; Wheeler R; Weber R; Rosenthal DI; Nguyen-Tân PF; Westra WH; Chung CH; Jordan RC; Lu C; Kim H; Axelrod R; Silverman CC; Redmond KP; Gillison ML
N Engl J Med; 2010 Jul; 363(1):24-35. PubMed ID: 20530316
[TBL] [Abstract][Full Text] [Related]
9. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
10. Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer.
Chen AM; Li J; Beckett LA; Zhara T; Farwell G; Lau DH; Gandour-Edwards R; Vaughan AT; Purdy JA
Laryngoscope; 2013 Jan; 123(1):152-7. PubMed ID: 23008061
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
13. Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer.
Burr AR; Harari PM; Ko HC; Bruce JY; Kimple RJ; Witek ME
Oral Oncol; 2019 May; 92():52-56. PubMed ID: 31010623
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma.
de Sousa LG; Lazar Neto F; Dal Lago EA; Sikora A; Hanna E; Moreno A; Phan J; Glisson BS; Bell D; Ferrarotto R
Oral Oncol; 2023 Mar; 138():106311. PubMed ID: 36702015
[TBL] [Abstract][Full Text] [Related]
15. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
16. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort.
Liu JC; Parajuli S; Blackman E; Gibbs D; Ellis A; Hull A; Beck JR; Giri V; Iherjirka P; Khurana JS; Ragin CR
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E867-72. PubMed ID: 25962720
[TBL] [Abstract][Full Text] [Related]
18. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
19. Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy.
Jackson RS; Sinha P; Zenga J; Kallogjeri D; Suko J; Martin E; Moore EJ; Haughey BH
Ann Surg Oncol; 2017 Nov; 24(12):3494-3501. PubMed ID: 28808988
[TBL] [Abstract][Full Text] [Related]
20. Timing of Postoperative Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
Townsend M; DeWees T; Gross J; Daly M; Gay H; Thorstad W; Jackson RS
Otolaryngol Head Neck Surg; 2019 Aug; 161(2):297-306. PubMed ID: 31159646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]